MTOR (mammalian target of rapamycin) inhibition with RAD001 induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitizes DLBCL cells to rituximab therapy.

Title:: MTOR (mammalian target of rapamycin) inhibition with RAD001 induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitizes DLBCL cells to rituximab therapy.
Document type:: Meeting Abstract
Author(s):: Wanner, K; Hipp, S; Peschel, C; Decker, T
Journal title abbreviation:: Blood
Year:: 2004
Journal volume:: 104
Journal issue:: 11
Pages contribution:: 239B-239B
Language:: eng
Print-ISSN:: 0006-4971
TUM Institution:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Occurrences: